JP2023507094A5 - - Google Patents
Info
- Publication number
- JP2023507094A5 JP2023507094A5 JP2022535816A JP2022535816A JP2023507094A5 JP 2023507094 A5 JP2023507094 A5 JP 2023507094A5 JP 2022535816 A JP2022535816 A JP 2022535816A JP 2022535816 A JP2022535816 A JP 2022535816A JP 2023507094 A5 JP2023507094 A5 JP 2023507094A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cgrp
- agent
- active component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962949351P | 2019-12-17 | 2019-12-17 | |
| US62/949,351 | 2019-12-17 | ||
| PCT/US2020/065452 WO2021127070A1 (en) | 2019-12-17 | 2020-12-17 | Intranasal pharmaceutical compositions of cgrp inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023507094A JP2023507094A (ja) | 2023-02-21 |
| JP2023507094A5 true JP2023507094A5 (https=) | 2023-12-12 |
Family
ID=76478147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535816A Pending JP2023507094A (ja) | 2019-12-17 | 2020-12-17 | Ｃｇｒｐ阻害剤の鼻腔内医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220401439A1 (https=) |
| EP (1) | EP4076395A4 (https=) |
| JP (1) | JP2023507094A (https=) |
| KR (1) | KR20220114613A (https=) |
| CN (1) | CN114980862A (https=) |
| AU (1) | AU2020408705A1 (https=) |
| BR (1) | BR112022011892A2 (https=) |
| CA (1) | CA3164445A1 (https=) |
| IL (1) | IL293647A (https=) |
| MX (1) | MX2022007336A (https=) |
| WO (1) | WO2021127070A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12521389B2 (en) * | 2019-06-14 | 2026-01-13 | The Regents Of The University Of California | Therapeutic approach to lung disease |
| WO2022109077A1 (en) * | 2020-11-19 | 2022-05-27 | Biohaven Pharmaceutical Holding Company Ltd. | Compositions for improved delivery of cgrp inhibitors |
| JP1706573S (ja) * | 2021-02-15 | 2022-02-01 | 鼻スプレー器 | |
| WO2023064195A1 (en) * | 2021-10-11 | 2023-04-20 | Pfizer Ireland Pharmaceuticals | Cgrp antagonists for treating trigeminal neuralgia |
| CN115429882B (zh) * | 2022-10-19 | 2024-08-06 | 上海交通大学医学院附属第九人民医院 | 伤害性感觉神经细胞调控药物的用途 |
| CA3252054A1 (en) | 2022-11-09 | 2024-05-16 | Tapi Czech Industries S.R.O. | SOLID FORMS OF ZAVÉGÉPANT HYDROCHLORIDE AND THEIR PREPARATION PROCESS |
| CN116003387B (zh) * | 2022-11-20 | 2024-03-26 | 药康众拓(北京)医药科技有限公司 | 一种氘代吲唑丙酰胺类化合物、药物组合物和用途 |
| JP1773931S (ja) * | 2023-05-17 | 2024-06-25 | 鼻スプレー器 | |
| CA225743S (fr) * | 2023-05-17 | 2024-09-12 | Aptar France Sas | Dispositif pour spray nasal |
| CA225744S (fr) * | 2023-05-17 | 2024-09-12 | Aptar France Sas | Dispositif pour spray nasal |
| GB202308123D0 (en) * | 2023-05-31 | 2023-07-12 | Orexo Ab | New copmosition |
| CN120733002B (zh) * | 2025-09-03 | 2025-11-25 | 华中科技大学同济医学院附属同济医院 | Cgrp受体小分子拮抗剂在制备治疗嗜酸性慢性鼻窦炎伴鼻息肉的药品中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040076587A1 (en) * | 2002-06-19 | 2004-04-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical composition for intranasal administration containing a CGRP antagonist |
| US8481546B2 (en) * | 2010-03-30 | 2013-07-09 | Bristol-Myers Squibb Company | CGRP receptor antagonist |
| US20160199600A1 (en) * | 2013-09-11 | 2016-07-14 | Bixa Research And Health Inc. | Single use intranasal atomizer |
| WO2017001433A1 (en) * | 2015-06-29 | 2017-01-05 | Galderma Research & Development | Cgrp receptor antagonist compounds for topical treatment of skin disorders |
| GB201519194D0 (en) * | 2015-10-30 | 2015-12-16 | Heptares Therapeutics Ltd | CGRP receptor antagonists |
| KR102444717B1 (ko) * | 2016-04-15 | 2022-09-16 | 하. 룬드벡 아크티에셀스카브 | 인간화 항-pacap 항체 및 그의 용도 |
| CN109476639B (zh) * | 2016-07-22 | 2021-02-26 | 橘生药品工业股份有限公司 | 吡咯烷衍生物 |
| US20190135927A1 (en) * | 2017-09-29 | 2019-05-09 | Bhl Patent Holdings, Llc | Migraine, headache, chronic pain treatment, and prophylaxis options |
| MX2020009856A (es) * | 2018-03-25 | 2020-10-08 | Biohaven Pharm Holding Co Ltd | Rimegepant para trastornos relacionados con el peptido relacionado con el gen para calcitonina (cgrp). |
| AU2020259461A1 (en) * | 2019-04-18 | 2021-11-11 | Allergan Sales, Llc | CGRP antagonists for the treatment of medication overuse headache, post-traumatic headache, post-concussion syndrome and vertigo |
-
2020
- 2020-12-17 CN CN202080086534.4A patent/CN114980862A/zh active Pending
- 2020-12-17 MX MX2022007336A patent/MX2022007336A/es unknown
- 2020-12-17 US US17/769,966 patent/US20220401439A1/en not_active Abandoned
- 2020-12-17 AU AU2020408705A patent/AU2020408705A1/en active Pending
- 2020-12-17 WO PCT/US2020/065452 patent/WO2021127070A1/en not_active Ceased
- 2020-12-17 KR KR1020227024199A patent/KR20220114613A/ko active Pending
- 2020-12-17 JP JP2022535816A patent/JP2023507094A/ja active Pending
- 2020-12-17 BR BR112022011892A patent/BR112022011892A2/pt not_active Application Discontinuation
- 2020-12-17 EP EP20903976.7A patent/EP4076395A4/en not_active Withdrawn
- 2020-12-17 CA CA3164445A patent/CA3164445A1/en active Pending
- 2020-12-17 IL IL293647A patent/IL293647A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023507094A5 (https=) | ||
| ES2626134T3 (es) | Composiciones de bepotastina | |
| AU2007298814B2 (en) | Galenic form for the trans-mucosal delivery of active ingredients | |
| KR101862415B1 (ko) | 상승적 항바이러스 조성물 및 이의 용도 | |
| US5688532A (en) | Antiallergic spray preparations | |
| US20190231686A1 (en) | Methods for treating cystic fibrosis and other diseases affecting mucosal surfaces | |
| EA008165B1 (ru) | Композиции для лечения простуды | |
| JP2014509655A (ja) | 鼻腔内ベンゾジアゼピン薬剤学的組成物 | |
| KR20000016781A (ko) | 데스모프레신의 경비투여 | |
| WO2016067283A1 (en) | Virucidal compositions comprising tannins for nasal and pulmonary administration | |
| RU2018143564A (ru) | Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа | |
| JP2019516797A5 (https=) | ||
| US20170266111A1 (en) | Local administration-type pharmaceutical for improving dysphagia | |
| ES2595257T3 (es) | Mejoras en o relativas a composiciones de apomorfina bucofaríngeas | |
| RU2008110933A (ru) | Применение амброксола для лечения риновирусных инфекций | |
| JP2025516040A (ja) | 鼻腔内バクロフェン | |
| CN102137656A (zh) | 用于鼻内投予的酮咯酸医药调配物 | |
| RU2762506C1 (ru) | Средство для аппликации полости рта и носа и способ его применения в составе комплексной терапии инфекционно-воспалительных заболеваний носовой и ротовой полости | |
| MX2013010456A (es) | Uso de una composicion pulverizable que contiene ambroxol. | |
| US9974768B2 (en) | Pharmaceutical for improving dysphagia | |
| US12485093B2 (en) | Composition for use as an antiviral in the form of nasal drops and in nebulisers | |
| KR102088662B1 (ko) | 연하장애 개선용 의약품 | |
| JP2023538859A5 (https=) | ||
| WO2023144614A1 (en) | Nasal compositions and methods thereof | |
| ES2882290A1 (es) | Yodo inorgánico administrable por via respiratoria y su uso como antiséptico de la vía aérea |